A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals
European Journal of Clinical Pharmacology December 22, 2025 Claudia Pisanu, Shungo Imai, Masami Tsuchiya et al. 3 citations
Esketamine, used for treatment-resistant depression, shows potential adverse effects and drug-drug interaction signals when analyzed in real-world data. The findings highlight risks that clinicians should consider when prescribing esketamine, particularly regarding possible interactions with other medications. The analysis underscores the need for careful monitoring of patients receiving esketamine to manage and mitigate these risks.